Forendo Pharma (private company)

Forendo Pharma is a drug development company based in Turku, Finland, with core competence in organ specific hormone mechanisms, giving new opportunities to unmet needs in women ́s and men ́s health.

Companies with similar profile to Forendo Pharma:

Company	Criteria
NMD Pharma 66%	Similar verticals: Health services, Pharma Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
AFYX Therapeutics 66%	Similar verticals: Health services, Pharma Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Synoste Oy 65%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Innovestor Ventures At least one other investor: Finnvera Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Galecto Biotech 65%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Novo Seeds, Sunstone Life Science Ventures At least one other investor: Merck Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
AMRA 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Novo Seeds Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
OxThera 55%	Similar verticals: Pharma Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Acarix 55%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
ITBMed 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Asarina Pharma 54%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Glucostratus (Mendor) 53%	Similar verticals: Health services Similar business models: B2B At least one other investor: Finnvera Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Aprea Therapeutics 53%	Similar verticals: Health services Similar business models: B2B At least one other investor: Karolinska Development Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Modus Therapeutics 53%	Similar verticals: Health services Similar business models: B2B At least one other investor: Karolinska Development Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
MinervaX 45%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Novo Seeds, Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD
Tenboron 45%	Similar verticals: Health services Similar business models: B2B At least one vc investor: Innovestor Ventures At least one other investor: Finnvera
Vaccibody 44%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD
Nanoform Finland 44%	Similar verticals: Health services, Pharma Similar business models: B2B Total raised in a similar range: 10M+ USD
Gesynta Pharma 44%	Similar verticals: Health services, Pharma Similar business models: B2B At least one other investor: Karolinska Development
BitBar 44%	Similar business models: B2B At least one vc investor: Innovestor Ventures At least one other investor: Finnvera Minim one investor from outside Scandinavia: Yes
Orphazyme 44%	Similar business models: B2B At least one vc investor: Sunstone Life Science Ventures Total raised in a similar range: 10M+ USD Minim one investor from outside Scandinavia: Yes
Athera 44%	Similar verticals: Health services, Pharma Similar business models: B2B At least one other investor: Karolinska Development